Cross sectional study of conventional cervical smear, monolayer cytology, and human papillomavirus DNA testing for cervical cancer screening

British Medical Journal

Volumn 326, Issue 7392, 2003, Pages 733-736

  Coste, Joël ^a   Cochand Priollet, Béatrix ^b   De Cremoux, Patricia ^c   Le Galès, Catherine ^d   Cartier, Issabelle ^e   Molinié, Vincent ^f   Labbé, Sylvain ^g   Vacher Lavenu, Marie Cécile ^a   Vielh, Philippe ^c  

^a Université Paris V ^*  (France)

^b HÔPITAL LARIBOISIÈRE   (France)

^c INSTITUT CURIE   (France)

^d INSERM   (France)

^e Laboratoire Cartier   (France)

^f FOCH HOSPITAL   (France)

^g Lab d'Anat Cytologie Pathologique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; CANCER CYTODIAGNOSIS; CANCER SCREENING; COLPOSCOPY; CYTODIAGNOSIS; DIAGNOSTIC ACCURACY; DNA DETERMINATION; FEMALE; GYNECOLOGIC CANCER; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MONOLAYER CULTURE; NONHUMAN; PRIORITY JOURNAL; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS INFECTION; WART VIRUS;

CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; CROSS-SECTIONAL STUDIES; CYTODIAGNOSIS; DNA, VIRAL; FEMALE; HUMANS; MASS SCREENING; OBSERVER VARIATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SENSITIVITY AND SPECIFICITY; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0037420528     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Nanda K, McCrory DC, Myers ER, Bastian LA, Hasselblad V, Hickey JD, et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med 2000;132:810-9.
2. Hartmann KE, Nanda K, Hall S, Myers E. Technologic advances for evaluation of cervical cytology: is newer better? Obstet Gynecol Surv 2001;56:765-74.
3. Merea E, Le Galès C, Cochand-Priollet B, Cartier I, de Cremoux P, Vacher-Lavenu MC, et al. Cost of screening for cancerous and precancerous lesions of the cervix. Diagn Cytopathol 2002;27:251-7.
4. Cochand-Priollet B, Le Galès C, de Cremoux P, Molinié V, Sastre-Garau X, Vacher-Lavenu MC, et al. Cost-effectiveness of monolayers and humanpapillomavirus testing compared to that of conventional Papanicolaou smears for cervical cancer screening: protocol of the study of the French Society, of Clinical Cytology. Diagn Cytopathol 2001;24:412-20.
5. Reid MC, Lachs MS, Feinstein AR. Use of methodological standards in diagnostic test research. Getting better but still not good. JAMA 1995;274:645-51.
6. Staff A, Wilbanks GD. An international terminology of colposcopy: report of the Nomenclature Committee of the International Federation of Cervical Pathology and Colposcopy. Obstet Gynecol 1991;77:313-4.
7. The Bethesda system for reporting cervical/vaginal cytologic diagnoses: revised after the second National Cancer Institute Workshop, April, 29-30, 1991. Acta Cytol 1993;37:115-24.
8. Poljak M, Brencic A, Seme K, Vince A, Marin IJ. Comparative evaluation of first- and second-generation digene hybrid capture assays for detection of human papillomaviruses associated with high or intermediate risk for cervical cancer. J Clin Microbiol 1999;37:796-7.
9. Fleiss J. Statistical methods for rates and proportions. New York: Wiley, 1981.
10. Hutchinson ML, Zahniser DJ, Sherman ME, Herrero R, Alfaro M, Bratti MC, et al. Utility of liquid-based cytology, for cervical carcinoma screening: results of a population-based study conducted in a region of Costa Rica with a high incidence of cervical carcinoma. Cancer 1999;87:48-55.
11. Sheets EE, Constantine NM, Dimisco S, Dean B, Cibas ES. Colposcopically directed biopsy provide a basis for comparing the accuracy of ThinPrep and Papanicolaou smears. J Gynecol Tech 1995;1:27-33.
12. Bishop JW, Bigner SH, Colgan TJ, Husain M, Howell LP, McIntosh KM, et al. Multicenter masked evaluation of AutoCyte PREP thin layers with matched conventional smears. Including initial biopsy results. Acta Cytol 1998;42:189-97.
13. Roberts JM, Gurley AM, Thurloe JK, Bowditch R, Laverty CRA. Evaluation of the Thin Prep pap test as an adjunct to the conventional Pap smear. Med J Aust 1997;167:466-9.
14. Bolick DR, Hellman DJ. Laboratory implementation and efficacy assessment of the ThinPrep cervical cancer screening system. Acta Cytol 1998;42:209-13.
15. Park IA, Lee SN, Chae SW, Park KH, Kim JW, Lee HP. Comparing the accuracy of ThinPrep Pap tests and conventional Papanicolaou smears on the basis of the histologic diagnosis: a clinical study of women with cervical abnormalities. Acta Cytol 2001;45:525-31.
16. Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ, et al. Identifying women with cervical neoplasia: using human papillomavirus DNA testing tor equivocal Papanicolaou results. JAMA 1999;281:1605-10.
17. Ronnett BM, Manos MM, Ransley JE, Fetterman BJ, Kinney WK, Hurley LB, et al. Atypical glandular cells of undetermined significance (AGUS): cytopathologic features, histopathologic results, and human papillomavirus DNA detection. Hum Pathol 1999;30:816-25.
18. Bergeron C, Jeannel D, Poveda J, Cassonnet P, Orth G. Human papillomavirus testing in women with mild cytologic atypia. Obstet Gymecol 2000;95:821-7.
19. Schneider A, Hoyer H, Lotz B, Leistritza S, Kuhne-Heid R, Nindl I, et al. Screening for high-grade cervical intra-epithelial neoplasia and cancer by testing for high-risk HPV, routine cytology or colposcopy. Int J Cancer 2000;89:529-34.
20. Ferenczy A, Robitaille J, Franco E, Arseneau J, Pichart RM, Wright TC. Conventional cervical cytologic smears vs. Thin Prep smears. A paired comparaison study of cervical cytology. Acta Cytol 1996;40:1136-42.
21. Bergeron C, Bishop J, Lemarie A, Cas F, Ayivi J, Huynh B, et al. Accuracy of thin-layer cytology in patients undergoing cervical cone biopsy. Acta Cytol 2001;45:519-24.
22. Bernstein SJ, Sanchez-Ramos L, Ndubisi B. Liquid-based cervical cytologic smear study and conventional Papanicolaou smears: a metaanalysis of prospective studies comparing cytologic diagnosis and sample adequacy. Am J Obstet Gynecol 2001;185:308-17.
23. Kaufman RH. Is there a role for human papillomavirus testing in clinical practice? Obstet Gynecol 2001;98:724-5.